Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)
The DOI matches its Crossref record; 92 of the 93 references it cites were found in a registry or an index.
Abstract
Background Antimicrobial de-escalation (ADE) is a strategy of antimicrobial stewardship, aiming at preventing the emergence of antimicrobial resistance (AMR) by decreasing the exposure to broad-spectrum antimicrobials. There is no high-quality research on ADE and its effects on AMR. Its definition varies and there is little evidence-based guidance for clinicians to use ADE in the intensive care unit (ICU). Methods A task force of 16 international experts was formed in November 2016 to provide with guidelines for clinical practice to develop questions targeted at defining ADE, its effects on the ICU population and to provide clinical guidance. Groups of 2 experts were assigned 1-2 questions each within their field of expertise to provide draft statements and rationale. A Delphi method, with 3 rounds and an agreement threshold of 70% was required to reach consensus. Results We present a comprehensive document with 13 statements, reviewing the evidence on the definition of ADE, its effects in the ICU population and providing guidance for clinicians in subsets of clinical scenarios where ADE may be considered. Conclusion ADE remains a topic of controversy due to the complexity of clinical scenarios where it may be applied and the absence of evidence to the effects it may have on antimicrobial resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ICU studies and expert statements support narrowing therapy when the clinical and microbiological evidence permits, while cautioning against indiscriminate discontinuation in unstable patients (19–21).”
From Day-4 antipseudomonal and anti-MRSA de-escalation was not associated with higher mortality in critically ill patients with sepsis (2026) · cites this paper as [21]
In the citing paper
“We identified direct evidence from 13 studies (1968 patients) [277], including 1 RCT [278]. In our meta-analysis, we observed improved short-term mortality in patients who were de-escalated (RR 0.72; 95% CI 0.57–0.91) (Supplementary Appendix 2).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [277]
In the citing paper
“Most studies were observational, and there are concerns that de-escalation is used primarily in patients who are getting better, which is why the reported improved short-term mortality should be interpreted with caution [277, 279].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [277]
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw118 · Cited by 3,061
Chastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217
Self-citationPharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101
Roberts, J. A., Paul, S. K., Akova, M., Bassetti, M., De Waele, J. J., Dimopoulos, G., Kaukonen, K.-M., Koulenti, D., Martin, C., Montravers, P., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu027 · Cited by 1,090
Self-citationThe timing of early antibiotics and hospital mortality in sepsis.
Liu, V. X., Fielding-Singh, V., Greene, J. D., Baker, J. M., Iwashyna, T. J., Bhattacharya, J., & Escobar, G. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201609-1848oc · Cited by 1,006
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Trial of short-course antimicrobial therapy for intraabdominal infection.
Sawyer, R. G., Claridge, J. A., Nathens, A. B., Rotstein, O. D., Duane, T. M., Evans, H. L., Cook, C. H., O’Neill, P. J., Mazuski, J. E., Askari, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411162 · Cited by 747
Averbuch, D., Orasch, C., Cordonnier, C., Livermore, D. M., Mikulska, M., Viscoli, C., Gyssens, I. C., Kern, W. V., Klyasova, G., Marchetti, O., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.091025 · Cited by 632
Paul, M., Daikos, G. L., Durante-Mangoni, E., Yahav, D., Carmeli, Y., Benattar, Y. D., Skiada, A., Andini, R., Eliakim-Raz, N., Nutman, A., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30099-9 · Cited by 623
Kadri, S. S., Adjemian, J., Lai, Y. L., Spaulding, A. B., Ricotta, E., Prevots, D. R., Palmore, T. N., Rhee, C., Klompas, M., Dekker, J. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy378 · Cited by 605
Timbrook, T. T., Morton, J. B., McConeghy, K. W., Caffrey, A. R., Mylonakis, E., & LaPlante, K. L. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw649 · Cited by 569
Gutiérrez-Gutiérrez, B., Salamanca, E., de Cueto, M., Hsueh, P.-R., Viale, P., Paño-Pardo, J. R., Venditti, M., Tumbarello, M., Daikos, G., Cantón, R., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30228-1 · Cited by 512
Self-citationThe Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia
RELLO, J., GALLEGO, M., MARISCAL, D., SOÑORA, R., & VALLES, J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.1.9607030 · Cited by 467
Self-citationGarnacho-Montero, J., Gutiérrez-Pizarraya, A., Escoresca-Ortega, A., Corcia-Palomo, Y., Fernández-Delgado, E., Herrera-Melero, I., Ortiz-Leyba, C., & Márquez-Vácaro, J. A. (2014) · Intensive Care Medicine · doi:10.1007/s00134-013-3077-7 · Cited by 389
Self-citationPfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377
Paul, M., Lador, A., Grozinsky-Glasberg, S., & Leibovici, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub3 · Cited by 377
Jensen, J. U., Hein, L., Lundgren, B., Bestle, M. H., Mohr, T. T., Andersen, M. H., Thornberg, K. J., Løken, J., Steensen, M., Fox, Z., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821e8791 · Cited by 356
Kumar, A., Safdar, N., Kethireddy, S., & Chateau, D. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e96b91 · Cited by 340
Clinical Characteristics and Treatment Patterns Among Patients With Ventilator-Associated Pneumonia
Kollef, M. H., Morrow, L. E., Niederman, M. S., Leeper, K. V., Anzueto, A., Benz-Scott, L., & Rodino, F. J. (2006) · Chest · doi:10.1378/chest.129.5.1210 · Cited by 322
Self-citationPfaller, M. A., Andes, D., Diekema, D. J., Espinel-Ingroff, A., & Sheehan, D. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.09.002 · Cited by 314
Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients
Armand-Lefèvre, L., Angebault, C., Barbier, F., Hamelet, E., Defrance, G., Ruppé, E., Bronchard, R., Lepeule, R., Lucet, J.-C., El Mniai, A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01823-12 · Cited by 300
Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract Infections
Li, C., Du, X., Kuti, J. L., & Nicolau, D. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00294-06 · Cited by 289
De-escalation therapy in ventilator-associated pneumonia*
Rello, J., Vidaur, L., Sandiumenge, A., Rodríguez, A., Gualis, B., Boque, C., & Diaz, E. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145997.10438.28 · Cited by 249
Self-citationLeone, M., Bechis, C., Baumstarck, K., Lefrant, J.-Y., Albanèse, J., Jaber, S., Lepape, A., Constantin, J.-M., Papazian, L., Bruder, N., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3411-8 · Cited by 243
Tabah, A., Cotta, M. O., Garnacho-Montero, J., Schouten, J., Roberts, J. A., Lipman, J., Tacey, M., Timsit, J.-F., Leone, M., Zahar, J. R., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1199 · Cited by 220
Self-citationImpact of antimicrobial therapy on the gut microbiome
Bhalodi, A. A., van Engelen, T. S. R., Virk, H. S., & Wiersinga, W. J. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky530 · Cited by 198
Vallabhaneni, S., Cleveland, A. A., Farley, M. M., Harrison, L. H., Schaffner, W., Beldavs, Z. G., Derado, G., Pham, C. D., Lockhart, S. R., & Smith, R. M. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv163 · Cited by 187
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams
Weiss, E., Zahar, J.-R., Lesprit, P., Ruppe, E., Leone, M., Chastre, J., Lucet, J.-C., Paugam-Burtz, C., Brun-Buisson, C., Timsit, J.-F., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.03.013 · Cited by 180
Self-citationFor the DURAPOP Trial Group, Montravers, P., Tubach, F., Lescot, T., Veber, B., Esposito-Farèse, M., Seguin, P., Paugam, C., Lepape, A., Meistelman, C., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5088-x · Cited by 173
Association of fluconazole pharmacodynamics with mortality in patients with candidemia
Baddley, J. W., Patel, M., Bhavnani, S. M., Moser, S. A., & Andes, D. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00116-08 · Cited by 162
Sinnollareddy, M. G., Roberts, J. A., Lipman, J., Akova, M., Bassetti, M., De Waele, J. J., Kaukonen, K.-M., Koulenti, D., Martin, C., Montravers, P., et al. (2015) · Critical Care · doi:10.1186/s13054-015-0758-3 · Cited by 148
Self-citationMokart, D., Slehofer, G., Lambert, J., Sannini, A., Chow‐Chine, L., Brun, J. P., Berger, P., Duran, S., Faucher, M., Blache, J. L., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-3148-9 · Cited by 144
Ventilator-associated pneumonia: Breaking the vicious circle of antibiotic overuse*
Léone, M., Garcin, F., Bouvenot, J., Boyadjev, I., Visintini, P., Albanèse, J., & Martin, C. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000253404.69418.aa · Cited by 132
Álvarez-Lerma, F., Alvarez, B., Luque, P., Ruiz, F., Dominguez-Roldan, J.-M., Quintana, E., Sanz-Rodriguez, C., & the ADANN Study Group (2006) · Critical Care · doi:10.1186/cc4919 · Cited by 127
Morel, J., Casoetto, J., Jospé, R., Aubert, G., Terrana, R., Dumont, A., Molliex, S., & Auboyer, C. (2010) · Critical Care · doi:10.1186/cc9373 · Cited by 126
Dickstein, Y., Lellouche, J., Dalak, M. A. B., Schwartz, D. A., Nutman, A., Daitch, V., Yahav, D., Leibovici, L., Skiada, A., Antoniadou, A., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy988 · Cited by 125
Zelenitsky, S. A., Rubinstein, E., Ariano, R. E., Iacovides, H., Dodek, P., Mirzanejad, Y., & Kumar, A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.10.015 · Cited by 123
Iankova, I., Thompson-Leduc, P., Kirson, N. Y., Rice, B., Hey, J., Krause, A., Schonfeld, S. A., DeBrase, C. R., Bozzette, S., & Schuetz, P. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002928 · Cited by 106
Eachempati, S. R., Hydo, L. J., Shou, J., & Barie, P. S. (2009) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/ta.0b013e31819dca4e · Cited by 105
Paul, M., Dickstein, Y., & Raz‐Pasteur, A. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.05.023 · Cited by 104
Vazquez, J., Reboli, A. C., Pappas, P. G., Patterson, T. F., Reinhardt, J., Chin-Hong, P., Tobin, E., Kett, D. H., Biswas, P., & Swanson, R. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-97 · Cited by 101
Antibiotic strategies in severe nosocomial sepsis: Why do we not de-escalate more often?*
Heenen, S., Jacobs, F., & Vincent, J.-L. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182416ecf · Cited by 100
Giantsou, E., Liratzopoulos, N., Efraimidou, E., Panopoulou, M., Alepopoulou, E., Kartali-Ktenidou, S., & Manolas, K. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0619-x · Cited by 100
Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia
Joung, K. M., Lee, J.-A., Moon, S.-Y., Cheong, H. S., Joo, E.-J., Ha, Y.-E., Sohn, K. M., Chung, S. M., Suh, G. Y., Chung, D. R., et al. (2011) · Critical Care · doi:10.1186/cc10072 · Cited by 100
Madaras-Kelly, K., Jones, M., Remington, R., Hill, N., Huttner, B., & Samore, M. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/677633 · Cited by 99
Woerther, P., Lepeule, R., Burdet, C., Decousser, J., Ruppé, É., & Barbier, F. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.08.026 · Cited by 92
Gonzalez, L., Cravoisy, A., Barraud, D., Conrad, M., Nace, L., Lemarié, J., Bollaert, P.-E., & Gibot, S. (2013) · Critical Care · doi:10.1186/cc12819 · Cited by 89
Bus, L. D., Denys, W., Catteeuw, J., Gadeyne, B., Vermeulen, K., Boelens, J., Claeys, G., Waele, J. J. D., Decruyenaere, J. M. A., & Depuydt, P. O. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4301-z · Cited by 85
Self-citationHarris, P. N. A., Peleg, A. Y., Iredell, J. R., Ingram, P. R., Miyakis, S., Stewardson, A. J., Rogers, B. A., McBryde, E. S., Roberts, J. A., Lipman, J., et al. (2015) · Trials · doi:10.1186/s13063-014-0541-9 · Cited by 82
Self-citationJensen, R. H., Johansen, H. K., Søes, L. M., Lemming, L. E., Rosenvinge, F. S., Nielsen, L., Olesen, B., Kristensen, L., Dzajic, E., Astvad, K. M. T., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01763-15 · Cited by 77
De-escalation after empirical meropenem treatment in the intensive care unit: Fiction or reality?
Waele, J. J. D., Ravyts, M., Depuydt, P. O., Blot, S. I., Decruyenaere, J. M. A., & Vogelaers, D. (2010) · Journal of Critical Care · doi:10.1016/j.jcrc.2009.11.007 · Cited by 75
Self-citationBailly, S., Leroy, O., Montravers, P., Constantin, J., Dupont, H., Guillemot, D., Lortholary, O., Mira, J. P., Pérrigault, P.-F., Gangneux, J., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-4053-1 · Cited by 72
Self-citationKim, J. W., Chung, J., Choi, S.-H., Jang, H. J., Hong, S.-B., Lim, C.-M., & Koh, Y. (2012) · Critical Care · doi:10.1186/cc11197 · Cited by 72
Joffe, A. R., Muscedere, J., Marshall, J. C., Su, Y., & Heyland, D. K. (2008) · Journal of Critical Care · doi:10.1016/j.jcrc.2007.12.006 · Cited by 62
Garnacho-Montero, J., Díaz-Martín, A., Cantón-Bulnes, L., Ramírez, P., Sierra, R., Arias-Verdú, D., Rodríguez-Delgado, M., Loza-Vázquez, A., Rodriguez-Gomez, J., Gordón, M., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002867 · Cited by 62
Self-citationMoraes, R. B., Guillen, J. A. V., Zabaleta, W. J. C., & Borges, F. K. (2016) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20160044 · Cited by 61
Hospital-acquired pneumonia and de-escalation of antimicrobial treatment
Kollef, M. H. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00029 · Cited by 55
Self-citationMontravers, P., Augustin, P., Grall, N., Desmard, M., Allou, N., Marmuse, J.-P., & Guglielminotti, J. (2016) · Critical Care · doi:10.1186/s13054-016-1267-8 · Cited by 55
Antimicrobial stewardship programme in critical care medicine: A prospective interventional study
Ramos, J. R., Ramírez, P., Gordón, M., Villarreal, E., Frasquet, J., Poveda-Andrés, J. L., Salavert, M., & Catellanos, A. (2017) · Medicina Intensiva · doi:10.1016/j.medin.2017.07.002 · Cited by 54
Cowley, M. C., Ritchie, D. J., Hampton, N., Kollef, M. H., & Micek, S. T. (2019) · Chest · doi:10.1016/j.chest.2018.10.014 · Cited by 49
Self-citationSouza-Oliveira, A. C., Cunha, T. M., Passos, L. B. D. S., Lopes, G. C., Gomes, F. A., & Röder, D. V. D. D. B. (2016) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2016.06.006 · Cited by 46
Cortese, S., Adamo, N., Mohr-Jensen, C., Hayes, A. J., Bhatti, S., Carucci, S., Del Giovane, C., Atkinson, L. Z., Banaschewski, T., Simonoff, E., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013967 · Cited by 45
Antimicrobial de-escalation in septic cancer patients: is it safe to back down?
Paskovaty, A., Pastores, S. M., Gedrimaite, Z., Kostelecky, N., Riedel, E. R., & Seo, S. K. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-4016-6 · Cited by 40
Trupka, T., Fisher, K., Micek, S. T., Juang, P., & Kollef, M. H. (2017) · Critical Care · doi:10.1186/s13054-017-1772-4 · Cited by 33
Self-citationEvaluation of empiric antibiotic de-escalation in febrile neutropenia
Kroll, A., Corrigan, P. A., Patel, S. B., & Hawks, K. G. (2015) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155215597558 · Cited by 29
Does Antibiotic De-escalation for Nosocomial Pneumonia Impact Intensive Care Unit Length of Stay?
Knaak, E., Cavalieri, S. J., Elsasser, G. N., Preheim, L. C., Gonitzke, A., & Destache, C. J. (2012) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e318279ee87 · Cited by 28
Weiss, E., Zahar, J., Garrouste-Orgeas, M., Ruckly, S., Essaied, W. I., Schwebel, C., Timsit, J., & On behalf of the OUTCOMEREA Study Group (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4448-7 · Cited by 28
Self-citationLow-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock
Iizuka, Y., Sanui, M., Sasabuchi, Y., Lefor, A. K., Hayakawa, M., Saito, S., Uchino, S., Yamakawa, K., Kudo, D., Takimoto, K., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1764-4 · Cited by 28
Palacios-Baena, Z. R., Delgado-Valverde, M., Valiente-Méndez, A., Almirante, B., Gómez-Zorrilla, S., Borrell, N., Corzo, J. E., Gurguí, M., de la Calle, C., García-Álvarez, L., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1032 · Cited by 28
De-Escalation of Antibiotics Does Not Increase Mortality in Critically Ill Surgical Patients
Turza, K. C., Politano, A. D., Rosenberger, L. H., Riccio, L. M., McLeod, M. D., & Sawyer, R. G. (2015) · Surgical Infections · doi:10.1089/sur.2014.202 · Cited by 26
Hu, L., Yang, C., Huang, L., Cui, Y., Xu, D., Wu, C., & Tang, J. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.231529 · Cited by 26
Jaffal, K., Poissy, J., Rouzé, A., Préau, S., Sendid, B., Cornu, M., & Nseir, S. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0392-8 · Cited by 25
Ferreira, D., Grenouillet, F., Blasco, G., Samain, E., Hénon, T., Dussaucy, A., Millon, L., Mercier, M., & Pili‐Floury, S. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3791-4 · Cited by 23
Khan, R. A., & Aziz, Z. (2017) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-017-0499-2 · Cited by 23
Carlier, M., Roberts, J. A., Stove, V. V., Verstraete, A., Lipman, J., & Waele, J. J. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00409-15 · Cited by 21
Self-citationNucci, M., Colombo, A. L., Petti, M., Magana, M., Abreu, P., Schlamm, H. T., & Sanchez, S. P. (2014) · Mycoses · doi:10.1111/myc.12094 · Cited by 21
Gharibian, K. N., & Mueller, B. A. (2016) · Clinical Nephrology · doi:10.5414/cn108824 · Cited by 21
Salahuddin, N., Amer, L. G., Joseph, M., Elhazmi, A., Hawa, H., & Maghrabi, K. A. (2016) · Critical Care Research and Practice · doi:10.1155/2016/6794861 · Cited by 21
Mootsikapun, P., Hsueh, P.-R., Talwar, D., Co, V. M., Rajadhyaksha, V., & Ong, M.-L. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-219 · Cited by 20
Claeys, K. C., Schlaffer, K., Heil, E. L., Leekha, S., & Johnson, J. K. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy233 · Cited by 19
De-escalation Antimicrobial Chemotherapy in Critically Ill Patients: Pros and Cons
Antonelli, M. M., Mercurio, G., Di Nunno, S., Recchioni, G., & DeAngelis, G. (2001) · Journal of Chemotherapy · doi:10.1179/joc.2001.13.supplement-2.218 · Cited by 15
Alshukairi, A. N., Alserehi, H., El‐Saed, A., Kelta, M., Rehman, J. U., Khan, F. A., Alsalmi, H., Alattas, M., & Aslam, M. N. (2015) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2015.11.004 · Cited by 13
Chastre, J. E. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2696-z · Cited by 12
López-Cortés, L. E., Rosso-Fernández, C. M., Núñez‐Núñez, M., Lavín-Alconero, L., Bravo-Ferrer, J. M., Barriga, Á., Delgado-Valverde, M., Lupión, C., Retamar, P., & Rodríguez‐Baño, J. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015439 · Cited by 8
Schlaffer, K., Heil, E. L., Leekha, S., Johnson, J. K., & Claeys, K. C. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx163.1650 · Cited by 1
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Self-citationBloodstream infections in critically ill patients: an expert statement
Timsit, J.-F., Ruppé, E., Barbier, F., Tabah, A., & Bassetti, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05950-6 · Cited by 448
Self-citationEASL Clinical Practice Guidelines on acute-on-chronic liver failure
Moreau, R., Tonon, M., Krag, A., Angeli, P., Berenguer, M., Berzigotti, A., Fernandez, J., Francoz, C., Gustot, T., Jalan, R., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.021 · Cited by 375
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline
Sieswerda, E., de Boer, M. G. J., Bonten, M. M. J., Boersma, W. G., Jonkers, R. E., Aleva, R. M., Kullberg, B.-J., Schouten, J. A., van de Garde, E. M. W., Verheij, T. J., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.09.041 · Cited by 201
Self-citation
Metadata
- Authors
- Tabah, A., Bassetti, M., Kollef, M. H., Zahar, J.-R., Paiva, J.-A., Timsit, J.-F., Roberts, J. A., Schouten, J., Giamarellou, H., Rello, J., De Waele, J., Shorr, A. F., Leone, M., Poulakou, G., Depuydt, P., & Garnacho-Montero, J.
- Affiliations
- The University of Queensland (AU)
- University of Udine (IT)
- Washington University in St. Louis (US)
- Assistance Publique – Hôpitaux de Paris (FR)
- Universidade do Porto (PT)
- Radboud University Nijmegen (NL)
- Hygeia Hospital (GR)
- Université de Montpellier (FR)
- MedStar Washington Hospital Center (US)
- National and Kapodistrian University of Athens (GR)
- Ghent University Hospital (BE)
- Corresponding author
- Tabah, Alexis
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2019-11-28
- Volume
- 46
- Issue
- 2
- Pages
- 245-265
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2990292797
- Semantic Scholar
- 9847069faf7ab8225951bb2615afe5409e51bb05
- Cited by
- 191
- References
- 93
- Citations by year
- 2026: 25 · 2025: 29 · 2024: 33 · 2023: 20 · 2022: 36 · 2021: 18 · 2020: 30
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- QUT ePrints (Queensland University of Technology) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- antibiotic de-escalation, antimicrobial stewardship, antimicrobial resistance, critically ill patients, intensive care unit, broad-spectrum antimicrobials, clinical guidelines, expert consensus
- MeSH terms
- Antimicrobial Stewardship, Anti-Infective Agents, Critical Care, Europe, Expert Testimony, Humans, Intensive Care Units, Microbiology, Societies, Medical, Critical Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.